1. |
Netea MG, Domínguez-Andrés J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol, 2020, 20(6): 375-388.
|
2. |
Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol, 2019, 16(6): 356-371.
|
3. |
Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol, 2018, 19(7): 665-673.
|
4. |
Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity, 2015, 42(4): 607-612.
|
5. |
Cai X, Zhang L, Wei W. Regulatory B cells in inflammatory diseases and tumor. Int Immunopharmacol, 2019, 67: 281-286.
|
6. |
Cui J, Zou Z, Duan J, et al. Predictive values of PET/CT in combination with regulatory B cells for therapeutic response and survival in contemporary patients with newly diagnosed multiple myeloma. Front Immunol, 2021, 12: 671904.
|
7. |
Siewe B, Stapleton JT, Martinson J, et al. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8+ T cell function in vitro. J Leukoc Biol, 2013, 93(5): 811-818.
|
8. |
Peng B, Ming Y, Yang C. Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation. Cell Death Dis, 2018, 9(2): 109.
|
9. |
Neta R, Salvin SB. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol, 1974, 113(6): 1716-1725.
|
10. |
Wolf SD, Dittel BN, Hardardottir F, et al. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med, 1996, 184(6): 2271-2278.
|
11. |
Mizoguchi A, Mizoguchi E, Smith RN, et al. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med, 1997, 186(10): 1749-1756.
|
12. |
Zhao Q, Jung LK. Frequency of CD19+CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study. Pediatr Rheumatol Online J, 2018, 16(1): 44.
|
13. |
Dasgupta S, Dasgupta S, Bandyopadhyay M. Regulatory B cells in infection, inflammation, and autoimmunity. Cell Immunol, 2020, 352: 104076.
|
14. |
Hong M, Liao Y, Liang J, et al. Immunomodulation of human CD19+CD25high regulatory B cells via Th17/Foxp3 regulatory T cells and Th1/Th2 cytokines. Hum Immunol, 2019, 80(10): 863-870.
|
15. |
Zacca ER, Onofrio LI, Acosta CDV, et al. PD-L1+ regulatory B cells are significantly decreased in rheumatoid arthritis patients and increase after successful treatment. Front Immunol, 2018, 9: 2241.
|
16. |
Wang T, Mei Y, Li Z. Research progress on regulatory B cells in systemic lupus erythematosus. Biomed Res Int, 2019, 2019: 7948687.
|
17. |
Kim Y, Kim G, Shin HJ, et al. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis. J Neuroinflammation, 2018, 15(1): 300.
|
18. |
Gray M, Miles K, Salter D, et al. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A, 2007, 104(35): 14080-14085.
|
19. |
Gao N, Dresel J, Eckstein V, et al. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Arthritis Rheumatol, 2014, 66(10): 2849-2861.
|
20. |
Blair PA, Noreña LY, Flores-Borja F, et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity, 2010, 32(1): 129-140.
|
21. |
Lepse N, Abdulahad WH, Rutgers A, et al. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. Rheumatology (Oxford), 2014, 53(9): 1683-1692.
|
22. |
Yang X, Yang J, Chu Y, et al. T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus. PLoS One, 2014, 9(2): e88441.
|
23. |
Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol, 2007, 178(10): 6092-6099.
|
24. |
Murakami Y, Saito H, Shimizu S, et al. Increased regulatory B cells are involved in immune evasion in patients with gastric cancer. Sci Rep, 2019, 9(1): 13083.
|
25. |
Zhang L, Tai YT, Ho M, et al. Regulatory B cell-myeloma cell interaction confers immunosuppression and promotes their survival in the bone marrow milieu. Blood Cancer J, 2017, 7(3): e547.
|
26. |
Zou Z, Guo T, Cui J, et al. Real-world data combined with studies on regulatory B cells for newly diagnosed multiple myeloma from a tertiary referral hospital in south-western China. J Cancer, 2021, 12(9): 2633-2642.
|
27. |
Wejksza K, Lee-Chang C, Bodogai M, et al. Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α. J Immunol, 2013, 190(6): 2575-2584.
|
28. |
Lee-Chang C, Bodogai M, Martin-Montalvo A, et al. Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells. J Immunol, 2013, 191(8): 4141-4151.
|
29. |
Xiao X, Lao XM, Chen MM, et al. PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression. Cancer Discov, 2016, 6(5): 546-559.
|
30. |
Ye L, Zhang Q, Cheng Y, et al. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion. J Immunother Cancer, 2018, 6(1): 145.
|
31. |
Brinkhoff A, Zeng Y, Sieberichs A, et al. B-cell dynamics during experimental endotoxemia in humans. Biosci Rep, 2019, 39(5): BSR20182347.
|
32. |
Dai YC, Wang WD, Zhang JA, et al. MTB driven B cells producing IL-35 and secreting high level of IL-10 in the patients with active pulmonary tuberculosis. Mol Immunol, 2019, 112: 175-181.
|
33. |
Mishima Y, Oka A, Liu B, et al. Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells. J Clin Invest, 2019, 129(9): 3702-3716.
|
34. |
Zhang M, Zeng G, Yang Q, et al. Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cell. Tuberculosis (Edinb), 2014, 94(3): 238-244.
|
35. |
Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest, 2010, 120(6): 1836-1847.
|
36. |
Tebbe B, Wilde B, Ye Z, et al. Renal transplant recipients treated with calcineurin-inhibitors lack circulating immature transitional CD19+CD24hiCD38hi regulatory B-lymphocytes. PLoS One, 2016, 11(4): e0153170.
|